Valeo Pharma's 4Q and fiscal 2022 financials reveal record revenue

Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share news the company has released its financial results for the fourth quarter and year-ended October 31, 2022.

Saviuk told Proactive the company saw record quarterly revenue of $12.7 million in 4Q 2022, which is up 274% year over year. Valeo also reported record annual revenues of $27.7 million for 2022, compared to $13.6 million in 2021, up 105%.

Saviuk also shared more details about what driven the growth in revenue and what is planned in 2023 to fuel the momentum.

Contact Details


+1 347-449-0879

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.